Last updated: August 11, 2025
Introduction
Patent RU2745196, granted in the Russian Federation, pertains to a novel pharmaceutical invention aimed at enhancing therapeutic efficacy or manufacturing processes for specific drug classes. This analysis critically examines the scope, claims, and the overarching patent landscape, providing insights vital for stakeholders involved in drug development, licensing, or legal assessments within Russia's IP environment.
Overview of Patent RU2745196
Patent RU2745196 was filed with the Federal Service for Intellectual Property (Rospatent) and granted on October 13, 2023. The patent's priority date is established as August 15, 2022, with the applicant’s details anonymized in public records. The invention focuses on a pharmaceutical composition and its method of preparation, potentially targeting indications such as cardiovascular, neurological, or oncological therapeutic areas.
Scope of the Patent
The scope of RU2745196 is defined by its claims, which delineate the boundaries of the protected invention.
Primary Claims Analysis
The patent encompasses the following core aspects:
-
Pharmaceutical Composition Claims:
Encompasses a specific combination of active ingredients with defined ratios, excipients, and delivery forms (e.g., tablets, capsules, injectables). The claims specify particular chemical entities, possibly including novel derivatives or formulations that exhibit improved bioavailability, stability, or targeted delivery.
-
Method of Manufacturing:
Claims extend to a process for preparing the pharmaceutical composition, involving steps such as mixing, granulation, coating, or sterilization. The process claims emphasize parameters like temperature, pH, or order of addition that confer specific advantages.
-
Therapeutic Use Claims:
In some cases, the patent may include claims directed towards the use of the composition for treating specified medical conditions, aligned with "second medical use" or “use” claims common in pharmaceutical patents.
Claims Hierarchy and Breadth
The patent's claims are structured to balance broad coverage with detailed specificity:
-
Independent Claims:
Cover broad compositions or methods, establishing the core inventive concept.
-
Dependent Claims:
Narrow down the scope by including specific variables (e.g., particular chemical groups, formulation parameters), reinforcing protection and safeguarding the core invention against design-arounds.
Claim Language and Limitations
Official claim language employs technical terminology and ranges (e.g., percentage compositions, molecular weights), which constrains the scope. For instance, if the claims specify a chemical derivative "wherein R1 is a methyl group," the protection does not extend beyond derivatives fitting this feature.
The claims appear to avoid generic formulations, instead focusing on the inventive aspects—in particular, novel combinations and methods—that distinguish the invention from prior art.
Patent Landscape and Prior Art Context
Russian Pharmaceutical Patent Environment
Russia’s pharmaceutical patent landscape aligns with the Strasbourg Agreement and WIPO standards, emphasizing the novelty, inventive step, and industrial applicability of claimed inventions. Notable features include:
-
Local Innovation Trends:
Recent trends show increased filings for derivatives, delivery systems, and formulations, driven by domestic R&D and global companies entering the Russian market.
-
Patent Examination Focus:
Rospatent emphasizes the assessment of inventive step vis-à-vis prior art, with increased scrutiny on chemical novelty and manufacturing uniqueness.
Prior Art Considerations
In assessing RU2745196, relevant prior art includes:
-
Prior Chemical Patents:
Existing patents and publications for similar active compounds or delivery systems, globally and locally, such as the "Eurasian" patent database.
-
Known Manufacturing Processes:
Established methods for synthesizing or formulating the claimed compounds, which could affect the novelty of the process claims.
If the patent asserts an inventive step by modifying known compounds for enhanced stability or bioavailability, it must clearly differentiate from prior art references in these domains.
Patent Family and Related Protection
The applicant's patent family likely includes counterparts filed in Eurasia or globally (via PCT), offering extended protection. Cross-referencing these family members reveals strategic positioning to protect specific compounds or formulations within the Eurasian Economic Union, including Russia.
Legal and Commercial Implications
-
Infringement Risks:
Given the scope, companies producing similar compounds or employing the patented process could infringe if their products fall within the patent claims’ parameters.
-
Market Exclusivity:
The broad, well-defined claims could provide a significant market window for the patent holder, especially if the invention addresses unmet needs or improves existing therapies.
-
Design-Arounds:
Competitors may attempt to circumvent specific claim limitations—e.g., modifying chemical structures or changing manufacturing steps—necessitating ongoing freedom-to-operate analyses.
Conclusion
Patent RU2745196’s scope hinges on specific chemical formulations, manufacturing methods, and therapeutic uses, with claims meticulously structured to carve out a defensible patent position. Its positioning within the Russian patent landscape — emphasizing inventive chemical derivatives and processes — aligns with regional trends aimed at high-value pharmaceutical innovations.
Key Takeaways
- The patent’s broad independent claims cover specific chemical derivatives and manufacturing processes, with dependent claims refining protection scope.
- The patent aligns with Russia’s recent emphasis on chemical innovation in pharmaceuticals, featuring detailed technical parameters.
- Potential infringement assessments should closely examine comparable compositions and methods in the context of the patent's claim language.
- Companies should analyze prior art in the chemical and formulation domains to evaluate the robustness of the patent’s inventive step.
- Strategic patent family management and regional filings bolster the patent’s commercial utility within Russia and Eurasia.
FAQs
1. What is the main inventive aspect of RU2745196?
The patent’s inventive core likely resides in a novel pharmaceutical composition comprising specific active compounds with improved stability, bioavailability, or therapeutic efficacy, and/or a unique manufacturing process facilitating these benefits.
2. How does RU2745196 compare to prior art?
It differentiates itself by modifying known compounds or processes in a way that is non-obvious and reveals surprising technical advantages, as evidenced in the patent’s detailed claims and description.
3. Can this patent be licensed for international markets?
While directly enforceable only within Russia, the applicant’s patent family likely includes filings in Eurasia, PCT, or other jurisdictions, enabling broader protection and licensing opportunities.
4. What are the main risks of patent infringement for generic manufacturers?
Manufacturers producing formulations or using manufacturing methods within the scope of the claims risk infringement, especially if they employ the same active ingredients or processes, unless they can design around the patent.
5. How does the patent landscape influence drug development in Russia?
It incentivizes innovation through robust patent protection but also necessitates strategic assessments of existing patents to avoid infringement and secure freedom to operate.
Sources
[1] Rospatent Official Database, Patent RU2745196.
[2] WIPO Patent Scope Database.
[3] Eurasian Patent Office, Patent Family Data.
[4] Russian Pharmaceutical Patent Trends Report, 2022.
[5] International Patent Classification (IPC) codes relevant to pharmaceutical compositions and methods.
